← Eichor
Study identifier: NCT07249567 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Patients With COPD and PRISM

Condition: COPD  ·  Sponsor: Karabuk University

PhaseN/A
Planned participants60
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersYes

About this study

COPD is a preventable and treatable lung disease characterized by persistent and progressive airflow limitation. PRISm, on the other hand, is a spirometry pattern that does not meet COPD diagnostic criteria despite symptoms and functional impairments, but requires maintenance. PRISm can predispose to the development of COPD and exacerbations, and can reduce exercise capacity by reducing respiratory function and oxygen consumption. There are no studies in the literature comparing respiratory muscle strength, peripheral muscle strength, and oxygenation in PRISm, COPD, and healthy individuals. Therefore, this study aimed to evaluate these parameters and compare them with healthy individuals.

This description comes directly from the study's public registry record.

Talk to the study team

Musa Güneş, PhD  ·  03704789081  ·  musagunes52@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Karabuk University, Physiotherapy and Rehabilitation Application and Research CenterKarabük, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07249567